Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of the Effect of Donor CYP3A5 Gene Polymorphism on Early Tacrolimus Concentration and Postoperative Acute Renal Injury After Liver Transplantation

NCT06319391 is registered in ClinicalTrials.gov with Ziqiang Li as lead sponsor.

NCT NCT06319391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06319391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of the Effect of Donor CYP3A5 Gene Polymorphism on Early Tacrolimus Concentration and Postoperative Acute Renal Injury After Liver Transplantation
Lead sponsor
Ziqiang Li
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2023
Completion date
October 1, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

according to the diagnosis and grading criteria of acute kidney injury, the cases and grading of postoperative acute kidney injury in 60 patients were counted, complete and accurate statistical data of 60 patients, cyp3a5*3 genotypes of 60 donors and recipients were analyzed accurately, postoperative tacrolimus concentrations were accurately recorded in 60 patients, scientific and rigorous statistical analysis of data